Case report: Amelioration of insulin resistance in diabetes with dehydroepiandrosterone

American Journal of the Medical Sciences

Volumn 306, Issue 5, 1993, Pages 320-324

  Buffington, C K ^a   Pourmotabbed, G ^a   Kitabchi, A E ^a  

^a NONE   (United States)

Author keywords

Dexamethasone; DHEA; Insulin resistance; Non insulin dependent diabetes; Testosterone

Indexed keywords

DEXAMETHASONE; INSULIN; PRASTERONE; TESTOSTERONE;

ADOLESCENT; ANDROGEN THERAPY; ARTICLE; CASE REPORT; DRUG MIXTURE; FEMALE; HUMAN; HYPERANDROGENISM; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 0027364180     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199311000-00010     Document Type: Article

References (27)

1. G. Pourmotabbed B. Williams-Cleaves C. Buffington F. Stentz A.E. Kitabchi Dehydroepiandrosterone administration increases insulin sensitivity (abstract) Clin Res. 39 1991 836A
2. D.J. Evans R.G. Hoffmann R.K. Kalkhoff A.H. Kissebah Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in menopausal women J Clin Endocrinol Metab. 57 1983 304 310
3. A. Dunaif M. Graf J. Mandeli V. Laumas A. Dobrjansky Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia J Clin Endocrinol Metab. 65 1987 499 506
4. A.N. Peiris R.A. Mueller M.F. Struve G.A. Smith A.H. Kissebah Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women J Clin Endocrinol Metab. 64 1987 162 169
5. S. Smith V.A. Ravnikar R.L. Barbieri Androgen and insulin response to an oral glucose challenge in hyperandrogenic women Fertil Steril. 48 1987 72 77
6. E.D. Schriock C.K. Buffington G.D. Hubert B.R. Kurtz A.E. Kitabchi J.E. Buster J.R. Givens Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding J Clin Endocrinol Metab. 66 1988 1329 1331
7. D.L. Coleman E.H. Leiter R.W. Schwizer Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice Diabetes. 31 1982 830 833
8. E.H. Leiter W.G. Beamer D.L. Coleman C. Longcope Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: Relationship to antihyperglycemic effects Metabolism. 36 1987 863 869
9. M.P. Cleary J.F. Zisk Antiobesity effect of two different levels of dehydroepiandrosterone in lean and obese Zucker rats Int J Obes. 10 1986 193 204
10. M.P. Cleary The antiobesity effect of dehydroepiandrosterone in rats Proc Soc Exp Biol Med. 196 1991 8 16
11. C.K. Buffington A.E. Kitabchi J.R. Givens Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity in hyperandrogenic females Diabetes. 40 1991 693 700
12. A.E. Kitabchi C.K. Buffington J.R. Givens H. Inouye Role of adrenal and gonadal androgens in insulin action and metabolism Folia Endocrinology. 67 1991 203 213
13. A.E. Kitabchi C.K. Buffington J.R. Givens The role of testosterone and dehydroepiandrosterone on insulin resistance and sensitivity in hyperandrogenic females: Use of activated T-lymphocytes as an in vitro study model and its correlation to in vivo studies A. Dunaif J.R. Givens F.P. Haseltine G.R. Merrian Polycystic ovary syndrome 1991 Blackwell Scientific Publications Boston 289 305
14. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes. 28 1979 1039 1057
15. E. Bonoro P. Moghetti C. Zancanaro M. Cigolini M. Queren V. Cacciatori A. Corgnati M. Muggeo Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests and euglycemic clamp studies J Clin Endocrinol Metab. 68 1989 374 378
16. K. Yasuda E. Hines A.E. Kitabchi Hypercortisolism and insulin resistance: Comparative effects of prednisone, hydrocortisone, and dexamethasone on insulin binding to erythrocytes J Clin Endocrinol Metab. 55 1982 910 914
17. 125I-Insulin from heterogeneously labeled insulin molecules for biological studies Diabetes. 31 1982 1128 1131
18. J.E. Nestler C.O. Barlascini J.N. Clore W.G. Blackard Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men J Clin Endocrinol Metab. 66 1988 57 61
19. J.F. Mortola S.S.C. Yen The effect of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women J Clin Endocrinol Metab. 71 1990 696 704
20. L. Abrahamsson H. Hackl Catabolic effects and the influence on hormonal variables under treatment with gynodian-depot or dehydroepiandrosterone (DHEA) oenanthate Maturitas. 3 1981 225 234
21. J.C. Levy M. Burnett S. Manley N.F. Taylor C.W. Burke R.C. Turner Dehydroepiandrosterone reduces fasting plasma glucose but not prandial glucose profile or peripheral insulin resistance in Type 2 (NIDDM) diabetes (abstract) Diabetes. 40 1991 345A
22. M.K. McIntosh C.D. Berdanier Antiobesity effects of dehydroepiandrosterone are mediated by futile substrate cycling in hepatocytes of BHE/cdb Rats J Nutr. 121 1991 2037 2043
23. D.L. Coleman Therapeutic effects of dehydroepiandrosterone and its metabolites in diabetes-obesity mutants H. Lardy F. Stratman Hormones, Thermogenesis, and Obesity 1989 Elsevier New York 377 384
24. B. Wright J.R. Porter E.S. Browne F. Svec Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats Int J Obes. 16 1992 579 583
25. E.S. Brown B.E. Wright F. Svec Dehydroepiandrosterone: Antiglucocorticoid actions in mice Am J Med Sci. 303 1992 366 371
26. R.A. Rizza L.J. Mandarino J.E. Gerich Cortisol-induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action J Clin Endocrinol Metab. 54 1982 131 138
27. I.M. Amatruda J.N. Livingston D.H. Lockwood Cellular mechanisms of selected state of insulin resistance: Human obesity, glucocorticoid excess and chronic renal failure Diabetes Metab Rev. 3 1985 293 317